- Home
- CVR vs AIDX Comparison
CVR vs AIDX Comparison
Compare CVR & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVR | AIDX |
|---|---|---|
| Founded | 1920 | N/A |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Industrial Machinery/Components | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 9.2M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVR | AIDX |
|---|---|---|
| Price | $10.41 | $0.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.7K | ★ 320.0K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $27,890,260.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.35 | N/A |
| 52 Week Low | $8.50 | $0.54 |
| 52 Week High | $15.00 | $14.09 |
Technical Indicators
Market Signals| Indicator | CVR | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 31.20 |
| Support Level | $9.12 | $0.54 |
| Resistance Level | $11.10 | $1.00 |
| Average True Range (ATR) | 0.34 | 0.09 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 55.81 | 7.87 |
Price Performance
Historical ComparisonAbout CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.